𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment

✍ Scribed by Helen C Hurst

Book ID
120700807
Publisher
BioMed Central
Year
2001
Tongue
English
Weight
59 KB
Volume
3
Category
Article
ISSN
1465-5411

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Checkpoint Controls and Targets in Cance
Checkpoint Controls and Targets in Cancer Therapy Volume 2 || p27Kip1 as a Biomarker and Target for Treatment of Cancer
✍ Siddik, Zahid H. πŸ“‚ Article πŸ“… 2009 πŸ› Humana Press 🌐 English βš– 717 KB

Much work over the last two decades has firmly established that loss of cell cycle checkpoint regulation, and resultant unabated cellular proliferation, is an inherent characteristic of cancer. This loss may occur through aberration in any single component involved in signal transduction pathways th

ErbB4 increases the proliferation potent
ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy
✍ Alex Starr; Joel Greif; Akiva Vexler; Maia Ashkenazy-Voghera; Valery Gladesh; Ch πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 218 KB πŸ‘ 1 views

## Abstract Clinical and experimental data suggest that ErbB‐4, a member of the epidermal growth factor receptor family, may have a role in cancer progression and response to treatment. We found recently, using a retrospective clinical analysis, that expression of ErbB‐4 receptor is correlated with